Atlas Trials

NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe

Clinical trial NCT06641661 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06641661
Sponsor
Qianfoshan Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Gene PolymorphismASCVD
Start date
2024-11-01
Primary completion
2026-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.